A gut bacterium is showing up — or rather disappearing — across all three phases of COVID-19.
Severely ill patients have less of it.
Recovered patients get it back.
Long COVID patients don't.
Its name is Faecalibacterium prausnitzii. And what it does explains a lot. 👇
F. prausnitzii is one of the most abundant bacteria in a healthy human gut.
It produces butyrate — a molecule that:
• Fuels your colon lining
• Seals your gut barrier
• Suppresses inflammatory signals
• Regulates your immune system
When it disappears, all of that fails at once.
Severe COVID-19
A 2025 meta-analysis pooling data across 10 independent studies confirmed:
F. prausnitzii depletion: logFC = -1.24 (95% CI -1.68 to -0.80)
Translation: It was significantly lower in every severe COVID cohort analyzed.
The more depleted. The sicker the patient.
Recovery
Patients who fully recovered from COVID-19 showed normalization of their gut microbiome — including return of F. prausnitzii — within approximately 6 months.
Butyrate-producing bacteria were among the first to come back.
The gut was healing. The bacteria were the signal.
Long COVID
Liu et al. 2022 (Gut journal) tracked 106 Long COVID patients over 6 months.
F. prausnitzii and Bifidobacterium pseudocatenulatum showed the STRONGEST inverse correlation with Long COVID development of any bacteria studied.
Less of them at baseline = more likely to have persistent symptoms.
Why does this matter beyond the gut?
↓ F. prausnitzii → ↓ butyrate → gut barrier breaks down
→ inflammatory signals enter bloodstream
→ cross into the brain
→ microglial activation
→ brain fog, memory problems, fatigue
This is the same gut-brain pathway seen in Parkinson's and Alzheimer's disease.
Long COVID may be hijacking the same route.
A randomized controlled trial just tested this.
463 Long COVID patients. Synbiotic targeting gut bacteria (SIM01) vs placebo. 6 months.
Results (Lancet Infectious Diseases 2024):
Difficulty concentrating: 62% vs 39% alleviated ✓
Memory loss: 42% vs 27% ✓
Fatigue: 63% vs 43% ✓
Pulmonary symptoms: no significant difference.
The gut fixed the brain symptoms. Not the lungs. That tells us something.
What we do NOT yet know:
• Whether F. prausnitzii depletion causes Long COVID — or is caused by it — or both
• The SIM01 trial used vitamin C as placebo, not inert starch
• Results need independent replication
• Direct F. prausnitzii supplement does not exist yet
Association is strong. Causation is unproven. That's where the science actually is.
No F. prausnitzii supplement exists yet. But you can feed it.
NOTE: Probiotics carry real risks for immunocompromised individuals and the elderly. Always consult your doctor.
This is part of a disease series on Faecalibacterium prausnitzii — one gut bacterium found depleted across Parkinson's, Alzheimer's, MS, IBD, diabetes, cancer, and now Long COVID.
Parkinson’s x.com/Neuroscope_mp/…
Alzheimer’s x.com/Neuroscope_mp/…
Aging x.com/Neuroscope_mp/…
Full referenced deep-dive on coming soon
Follow @Neuroscope_mp so you don't miss the next thread.
Researchers studied 1,575 individuals aged 20 to 117 — including 297 centenarians.
Their guts looked younger than their age. And certain bacteria tell the story.
F. prausnitzii is part of it. Here's what the science shows. 👇
#Longevity #Aging #Microbiome
F. prausnitzii declines with normal aging — independent of disease.
In older adults, this depletion contributes to 'inflammaging' — the chronic low-grade inflammation that accelerates biological aging and raises the risk of neurodegeneration, metabolic disease, and immune dysfunction.
Butyrate loss is central.
Less F. prausnitzii means less butyrate means more gut permeability means more systemic inflammation.
Here's where it gets counterintuitive.
Pang et al. 2023 (Nature Aging) found that centenarians display youth-associated gut microbiome signatures — including higher species evenness and reduced opportunistic pathogens.
A 2022 study (Frontiers in Cellular and Infection Microbiology) found Faecalibacterium prausnitzii was significantly higher in young people vs the oldest-old, but the healthiest centenarians maintained more youthful microbial profiles.
Longevity may partly reflect preserved gut ecology.
Yesterday: Faecalibacterium prausnitzii depleted in Parkinson's disease.
Today: the same bacterium, a different brain disease ... Alzheimer's.
In Alzheimer's, its depletion triggers a completely different chain — one that targets the blood-brain barrier and drives neuroinflammation from the inside.
Here's the science 👇
#Alzheimers #GutBrainAxis
F. prausnitzii has been identified as depleted in Alzheimer's patients across multiple human cohort studies.
Ueda et al. 2021 (Cell Reports Medicine) identified specific F. prausnitzii strains as candidate targets for gut microbiome-based intervention in Alzheimer's-type dementia.
Depletion correlates with worse MMSE cognitive scores — the standard clinical test for dementia severity.
The AD mechanism is different from Parkinson's.
↓ F. prausnitzii
→ ↓ butyrate
→ HDAC inhibition lost
→ NF-kB pathway hyperactivated in microglia
→ TNF-alpha, IL-1beta, IL-6 elevation
→ accelerated amyloid-beta deposition
→ tau hyperphosphorylation
Butyrate also maintains claudin-5, the blood-brain barrier tight junction protein. When F. prausnitzii falls, the BBB becomes permeable to peripheral inflammation.
BREAKING 🧵
A major network meta-analysis (550 Parkinson’s patients + 456 controls) ...
Found that one gut bacterium is consistently missing in PD.
And lower levels correlate with worse balance and walking problems.
That bacterium is Faecalibacterium prausnitzii.
Here's what the science says 👇
#Parkinsons #GutBrainAxis
F. prausnitzii is one of the most abundant bacteria in a healthy gut, making up to 5% of your total microbiome.
It’s a butyrate producer (a key short-chain fatty acid).
Think of it as your gut’s natural anti-inflammatory firefighter.
It feeds colon cells, reduces inflammation, and sends signals to the brain.
In Parkinson’s, F. prausnitzii is consistently depleted.
Li et al. (2023) reviewed 26 human studies.
It was one of only 5 genera with repeated depletion across studies. A
A separate network meta-analysis (550 PD vs 456 controls) confirmed the same pattern across continents.
His neurologist used skin biopsy, gut markers, and inflammation testing to map his specific drivers.
Now they’re building a precision plan using today’s tools + tomorrow’s clinical trials: replace lost neurons, repair the gut, calm inflammation, and monitor closely.
This is what the future of Parkinson’s care is starting to look like.
Thread 🧠👇
Meet Henry, 64 — just diagnosed after months of a tremor in his right hand.
His neurologist didn’t stop at the clinical exam.
She ordered a skin biopsy for misfolded alpha-synuclein (positive) + a DaTscan.
It came back positive. Diagnosis confirmed.
This matters: up to 25% of Parkinson’s diagnoses based on symptoms alone are wrong.
Confirm the pathology first. These tests are available now.
Don’t skip this step.
Henry’s neurologist went deeper.
She had him track symptoms in detail and ran bloodwork + gut markers.
Two major clues emerged:
• Constipation and GI issues for nearly 10 years
• Elevated chronic low-grade inflammation markers
This pattern suggests “gut-first” Parkinson’s — a distinct Parkinson’s subtype.
Researchers are now using biomarkers like fecal calprotectin, short-chain fatty acids, and inflammatory panels to separate gut-driven PD from brain-first PD for better-targeted trials.
More biomarkers to define these two underlying root causes are In clinical research right now.
BREAKING: A blood-based protein test can reveal how fast your brain's support cells are aging.
If they’re aging too fast, your Alzheimer’s risk jumps 12.59x.
60,542 people.
7,000+ proteins.
40+ cell types.
This is one of the biggest aging papers of 2026.
Here's what it means for your brain. 🧠👇
Your body doesn't age as one unit.
Your liver cells, immune cells, neurons, gut cells — they all have their own biological clocks.
And they don't tick at the same speed.
This study used 7,000 proteins in blood to build aging clocks for 40+ different cell types.
20–25% of people showed accelerated aging in at least one cell type.
1–3% were aging fast in 10 or more cell types simultaneously.
Your chronological age? It barely predicts disease.
Your cellular age? That's a different story.
So what are astrocytes, and why do they keep showing up in Alzheimer's research?
Think of astrocytes as the brain's maintenance crew.
They:
→ Feed neurons
→ Clear metabolic waste
→ Maintain the blood-brain barrier
→ Regulate synapses
→ Control brain inflammation
When astrocytes age and malfunction, everything downstream starts to fail.
A 2025 NYU review (Gildea & Liddelow, Mol Neurodegeneration) confirmed:
Glial cells are the most transcriptionally altered cells in the aging brain.
Astrocyte aging is now a primary target for neurodegeneration prevention.
The neurons weren't first to fail. The support crew was.